A citation-based method for searching scientific literature

Lisa Mirabello, Bin Zhu, Roelof Koster, Eric Karlins, Michael Dean, Meredith Yeager, Matthew Gianferante, Logan G Spector, Lindsay M Morton, Danielle Karyadi, Leslie L Robison, Gregory T Armstrong, Smita Bhatia, Lei Song, Nathan Pankratz, Maisa Pinheiro, Julie M Gastier-Foster, Richard Gorlick, Silvia Regina Caminada de Toledo, Antonio S Petrilli, Ana Patino-Garcia, Fernando Lecanda, Miriam Gutierrez-Jimeno, Massimo Serra, Claudia Hattinger, Piero Picci, Katia Scotlandi, Adrienne M Flanagan, Roberto Tirabosco, Maria Fernanda Amary, Nilgün Kurucu, Inci Ergurhan Ilhan, Mandy L Ballinger, David M Thomas, Donald A Barkauskas, Gerardo Mejia-Baltodano, Patricia Valverde, Belynda D Hicks, Bin Zhu, Mingyi Wang, Amy A Hutchinson, Margaret Tucker, Joshua Sampson, Maria T Landi, Neal D Freedman, Susan Gapstur, Brian Carter, Robert N Hoover, Stephen J Chanock, Sharon A Savage. JAMA Oncol 2020
Times Cited: 48







List of co-cited articles
281 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Germline Mutations in Predisposition Genes in Pediatric Cancer.
Jinghui Zhang, Michael F Walsh, Gang Wu, Michael N Edmonson, Tanja A Gruber, John Easton, Dale Hedges, Xiaotu Ma, Xin Zhou, Donald A Yergeau,[...]. N Engl J Med 2015
539
29

The landscape of genomic alterations across childhood cancers.
Susanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, Ivo Buchhalter, Kortine Kleinheinz, Vasilisa A Rudneva, Pascal D Johann, Gnana Prakash Balasubramanian, Maia Segura-Wang, Sebastian Brabetz,[...]. Nature 2018
499
25


Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
18

Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.
D Matthew Gianferante, Lisa Mirabello, Sharon A Savage. Nat Rev Endocrinol 2017
188
18

Monogenic and polygenic determinants of sarcoma risk: an international genetic study.
Mandy L Ballinger, David L Goode, Isabelle Ray-Coquard, Paul A James, Gillian Mitchell, Eveline Niedermayr, Ajay Puri, Joshua D Schiffman, Gillian S Dite, Arcadi Cipponi,[...]. Lancet Oncol 2016
112
14

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.
Christian P Kratz, Maria Isabel Achatz, Laurence Brugières, Thierry Frebourg, Judy E Garber, Mary-Louise C Greer, Jordan R Hansford, Katherine A Janeway, Wendy K Kohlmann, Rose McGee,[...]. Clin Cancer Res 2017
202
14

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
Sebastian M Waszak, Paul A Northcott, Ivo Buchhalter, Giles W Robinson, Christian Sutter, Susanne Groebner, Kerstin B Grund, Laurence Brugières, David T W Jones, Kristian W Pajtler,[...]. Lancet Oncol 2018
143
14

Germline TP53 variants and susceptibility to osteosarcoma.
Lisa Mirabello, Meredith Yeager, Phuong L Mai, Julie M Gastier-Foster, Richard Gorlick, Chand Khanna, Ana Patiño-Garcia, Luis Sierrasesúmaga, Fernando Lecanda, Irene L Andrulis,[...]. J Natl Cancer Inst 2015
63
12

Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
Phuong L Mai, Ana F Best, June A Peters, Rosamma M DeCastro, Payal P Khincha, Jennifer T Loud, Renée C Bremer, Philip S Rosenberg, Sharon A Savage. Cancer 2016
193
12

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.
Sigbjørn Smeland, Stefan S Bielack, Jeremy Whelan, Mark Bernstein, Pancras Hogendoorn, Mark D Krailo, Richard Gorlick, Katherine A Janeway, Fiona C Ingleby, Jakob Anninga,[...]. Eur J Cancer 2019
130
12

Pathogenic Germline Variants in 10,389 Adult Cancers.
Kuan-Lin Huang, R Jay Mashl, Yige Wu, Deborah I Ritter, Jiayin Wang, Clara Oh, Marta Paczkowska, Sheila Reynolds, Matthew A Wyczalkowski, Ninad Oak,[...]. Cell 2018
278
12

Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.
Gaëlle Bougeard, Mariette Renaux-Petel, Jean-Michel Flaman, Camille Charbonnier, Pierre Fermey, Muriel Belotti, Marion Gauthier-Villars, Dominique Stoppa-Lyonnet, Emilie Consolino, Laurence Brugières,[...]. J Clin Oncol 2015
290
12

Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.
Tim Ripperger, Stefan S Bielack, Arndt Borkhardt, Ines B Brecht, Birgit Burkhardt, Gabriele Calaminus, Klaus-Michael Debatin, Hedwig Deubzer, Uta Dirksen, Cornelia Eckert,[...]. Am J Med Genet A 2017
88
12

Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.
D Williams Parsons, Angshumoy Roy, Yaping Yang, Tao Wang, Sarah Scollon, Katie Bergstrom, Robin A Kerstein, Stephanie Gutierrez, Andrea K Petersen, Abhishek Bavle,[...]. JAMA Oncol 2016
232
12

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.
M P Link, A M Goorin, A W Miser, A A Green, C B Pratt, J B Belasco, J Pritchard, J S Malpas, A R Baker, J A Kirkpatrick. N Engl J Med 1986
855
12

Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.
Xiang Chen, Armita Bahrami, Alberto Pappo, John Easton, James Dalton, Erin Hedlund, David Ellison, Sheila Shurtleff, Gang Wu, Lei Wei,[...]. Cell Rep 2014
375
10

Tumor Syndromes Predisposing to Osteosarcoma.
Meera Hameed, Diana Mandelker. Adv Anat Pathol 2018
29
17

Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Paul A Meyers, Cindy L Schwartz, Mark D Krailo, John H Healey, Mark L Bernstein, Donna Betcher, William S Ferguson, Mark C Gebhardt, Allen M Goorin, Michael Harris,[...]. J Clin Oncol 2008
445
10

Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy.
Yayan T Sundara, Marie Kostine, Arjen H G Cleven, Judith V M G Bovée, Marco W Schilham, Anne-Marie Cleton-Jansen. Cancer Immunol Immunother 2017
63
10

Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.
Jennifer A Perry, Adam Kiezun, Peter Tonzi, Eliezer M Van Allen, Scott L Carter, Sylvan C Baca, Glenn S Cowley, Ami S Bhatt, Esther Rheinbay, Chandra Sekhar Pedamallu,[...]. Proc Natl Acad Sci U S A 2014
241
10

Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.
Stefan S Bielack, Beate Kempf-Bielack, Günter Delling, G Ulrich Exner, Silke Flege, Knut Helmke, Rainer Kotz, Mechthild Salzer-Kuntschik, Matthias Werner, Winfried Winkelmann,[...]. J Clin Oncol 2002
10

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success.
Michael S Isakoff, Stefan S Bielack, Paul Meltzer, Richard Gorlick. J Clin Oncol 2015
639
10

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
D Malkin, F P Li, L C Strong, J F Fraumeni, C E Nelson, D H Kim, J Kassel, M A Gryka, F Z Bischoff, M A Tainsky. Science 1990
10

Sensitivity and predictive value of criteria for p53 germline mutation screening.
A Chompret, A Abel, D Stoppa-Lyonnet, L Brugiéres, S Pagés, J Feunteun, C Bonaïti-Pellié. J Med Genet 2001
194
10

Pediatric Cancer Predisposition and Surveillance: An Overview, and a Tribute to Alfred G. Knudson Jr.
Garrett M Brodeur, Kim E Nichols, Sharon E Plon, Joshua D Schiffman, David Malkin. Clin Cancer Res 2017
69
10

Genome-Informed Targeted Therapy for Osteosarcoma.
Leanne C Sayles, Marcus R Breese, Amanda L Koehne, Stanley G Leung, Alex G Lee, Heng-Yi Liu, Aviv Spillinger, Avanthi T Shah, Bogdan Tanasa, Krystal Straessler,[...]. Cancer Discov 2019
106
8

Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database.
Simona Ognjanovic, Magali Olivier, Tracy L Bergemann, Pierre Hainaut. Cancer 2012
143
8

Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency.
Michal Kovac, Claudia Blattmann, Sebastian Ribi, Jan Smida, Nikola S Mueller, Florian Engert, Francesc Castro-Giner, Joachim Weischenfeldt, Monika Kovacova, Andreas Krieg,[...]. Nat Commun 2015
160
8

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.
Paul A Meyers, Cindy L Schwartz, Mark Krailo, Eugenie S Kleinerman, Donna Betcher, Mark L Bernstein, Ernest Conrad, William Ferguson, Mark Gebhardt, Allen M Goorin,[...]. J Clin Oncol 2005
466
8

CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial.
Anne Gomez-Brouchet, Claire Illac, Julia Gilhodes, Corinne Bouvier, Sébastien Aubert, Jean-Marc Guinebretiere, Béatrice Marie, Frédérique Larousserie, Natacha Entz-Werlé, Gonzague de Pinieux,[...]. Oncoimmunology 2017
70
8

Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database.
Benjamin J Miller, Peter Cram, Charles F Lynch, Joseph A Buckwalter. J Bone Joint Surg Am 2013
93
8

ClinVar: improving access to variant interpretations and supporting evidence.
Melissa J Landrum, Jennifer M Lee, Mark Benson, Garth R Brown, Chen Chao, Shanmuga Chitipiralla, Baoshan Gu, Jennifer Hart, Douglas Hoffman, Wonhee Jang,[...]. Nucleic Acids Res 2018
955
8

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
Anita Villani, Ari Shore, Jonathan D Wasserman, Derek Stephens, Raymond H Kim, Harriet Druker, Bailey Gallinger, Anne Naumer, Wendy Kohlmann, Ana Novokmet,[...]. Lancet Oncol 2016
235
8

Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth.
Rajen J Mody, Yi-Mi Wu, Robert J Lonigro, Xuhong Cao, Sameek Roychowdhury, Pankaj Vats, Kevin M Frank, John R Prensner, Irfan Asangani, Nallasivam Palanisamy,[...]. JAMA 2015
227
8

Germline Elongator mutations in Sonic Hedgehog medulloblastoma.
Sebastian M Waszak, Giles W Robinson, Brian L Gudenas, Kyle S Smith, Antoine Forget, Marija Kojic, Jesus Garcia-Lopez, Jennifer Hadley, Kayla V Hamilton, Emilie Indersie,[...]. Nature 2020
36
11

A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.
Sarah Scollon, Amanda Knoth Anglin, Martha Thomas, Joyce T Turner, Kami Wolfe Schneider. J Genet Couns 2017
28
14

Frequent inactivating germline mutations in DNA repair genes in patients with Ewing sarcoma.
Andrew S Brohl, Rajesh Patidar, Clesson E Turner, Xinyu Wen, Young K Song, Jun S Wei, Kathleen A Calzone, Javed Khan. Genet Med 2017
38
10

Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.
L Diller, E Sexsmith, A Gottlieb, F P Li, D Malkin. J Clin Invest 1995
148
8

Germline GPR161 Mutations Predispose to Pediatric Medulloblastoma.
Matthias Begemann, Sebastian M Waszak, Giles W Robinson, Natalie Jäger, Tanvi Sharma, Cordula Knopp, Florian Kraft, Olga Moser, Martin Mynarek, Lea Guerrini-Rousseau,[...]. J Clin Oncol 2020
25
16

Germline BRCA2 mutations detected in pediatric sequencing studies impact parents' evaluation and care.
Michael F Walsh, Jennifer Kennedy, Megan Harlan, Alex Kentsis, Neerav Shukla, Jacob Musinsky, Stephen Roberts, Andrew L Kung, Mark Robson, Brian H Kushner,[...]. Cold Spring Harb Mol Case Stud 2017
11
36

Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool.
Marjolijn C J Jongmans, Jan L C M Loeffen, Esmé Waanders, Peter M Hoogerbrugge, Marjolijn J L Ligtenberg, Roland P Kuiper, Nicoline Hoogerbrugge. Eur J Med Genet 2016
58
8

A global reference for human genetic variation.
Adam Auton, Lisa D Brooks, Richard M Durbin, Erik P Garrison, Hyun Min Kang, Jan O Korbel, Jonathan L Marchini, Shane McCarthy, Gil A McVean, Gonçalo R Abecasis. Nature 2015
8

Analysis of protein-coding genetic variation in 60,706 humans.
Monkol Lek, Konrad J Karczewski, Eric V Minikel, Kaitlin E Samocha, Eric Banks, Timothy Fennell, Anne H O'Donnell-Luria, James S Ware, Andrew J Hill, Beryl B Cummings,[...]. Nature 2016
8

Translational biology of osteosarcoma.
Maya Kansara, Michele W Teng, Mark J Smyth, David M Thomas. Nat Rev Cancer 2014
539
8

Immuno-genomic landscape of osteosarcoma.
Chia-Chin Wu, Hannah C Beird, J Andrew Livingston, Shailesh Advani, Akash Mitra, Shaolong Cao, Alexandre Reuben, Davis Ingram, Wei-Lien Wang, Zhenlin Ju,[...]. Nat Commun 2020
51
8

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
Neyssa M Marina, Sigbjørn Smeland, Stefan S Bielack, Mark Bernstein, Gordana Jovic, Mark D Krailo, Jane M Hook, Carola Arndt, Henk van den Berg, Bernadette Brennan,[...]. Lancet Oncol 2016
185
8


Addition of pamidronate to chemotherapy for the treatment of osteosarcoma.
Paul A Meyers, John H Healey, Alexander J Chou, Leonard H Wexler, Pamela R Merola, Carol D Morris, Michael P Laquaglia, Michael G Kellick, Sara J Abramson, Richard Gorlick. Cancer 2011
98
8

Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes.
Thierry Frebourg, Svetlana Bajalica Lagercrantz, Carla Oliveira, Rita Magenheim, D Gareth Evans. Eur J Hum Genet 2020
43
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.